ProThera Biologics Inc. Secures $500,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=23707538-fc2a-451f-b536-2b21f69ed9b1&Preview=1 -
Date
6/24/2008 -
Company Name
ProThera Biologics Inc. -
Mailing Address
551 Warren Avenue East Providence, RI 02914 -
Company Description
The mission of the company is to develop novel products that exploit the promise of personalized medicine by leveraging on its proprietary technology of natural serine protease inhibitor proteins.
The company focuses on unmet medical needs by developing INTEGRATED theranostic and therapeutic biomolecules for serious human diseases such as sepsis and cancer. -
Website
http://www.protherabiologics.com -
Transaction Type
Venture Equity -
Transaction Amount
$500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Richard Horan of the Slater Technology Fund said, “With additional investment and with Rick Andrews coming on-board, we are excited about the prospects of accelerating the company’s efforts in the development of what promise to be significant advances in clinical medicine.” -
M&A Terms
-
Venture Investor
Slater Technology Fund
